UNFUCG
DashboardSearchChatBookmarksNotificationsActivityPremiumProfile
?
Home
Search
Chat
Saved
Profile
Episode
Neuroscientist Explains: Can Psychedelics Really Treat Depression?
~100 min
Episode Brief·YouTube

Neuroscientist Explains: Can Psychedelics Really Treat Depression?

Mark Hyman
Watch on YouTube Add to chat My bookmarks← All sources

TL;DR

The four things you'd lose by not watching

4 items

TL;DR

The four things you'd lose by not watching

4 items
1

Robin Carhart-Harris's 'entropic brain principle' explains that psychedelics increase brain entropy—unzipping compressed, rigid patterns—leading to mental flexibility and therapeutic breakthroughs for depression, PTSD, and addiction.

2

In a pivotal psilocybin trial for treatment-resistant depression, one patient who had failed 7+ antidepressants recovered fully and is still well 10 years later, illustrating that 1-3 psychedelic sessions can produce enduring remission.

3

Effective psychedelic treatment is not just the drug; it relies on a controlled set, setting, and skilled therapeutic support. Unsupervised use carries real risks of harm from impaired judgment or psychological destabilization.

4

Carhart-Harris predicts that psilocybin therapy will be a federally licensed medicine for depression within 5 years, while MDMA-assisted therapy for PTSD may arrive even sooner, ushering in a paradigm shift in psychiatry.

Notable quotes

Lines worth pulling out — contrarian, specific, or perfectly phrased

4 items
It's not that we shut off the default mode network. That's a popular in a sense uh myth uh that people like and you can get away with it, but it's not really true. You know, you're not turning it off, you're scrambling it up.
Sharp, memorable correction of a widespread public and scientific misconception.
We get stuck in reinforced ways of feeling, thinking, behaving. And that characterizes not all of mental illness but most of it. It's the principal component of mental illness getting stuck in these reinforced ways of being. Why do we do it? That's another question. I strongly suspect we do it because it's defensive.
Distills mental illness down to defensive rigidity and sets up the plasticity counter-argument clearly.
The evidence to date is a little underwhelming for micro doing. And part of the issue is that the trials have been um limited really. There there haven't been many. And when they've been done um they haven't often dosed for long enough in my view.
A leading researcher directly undercutting the hype around microdosing while leaving the door open for future research.
I do see it as like a system reset, you know, and then back to sort of default function. The idea is that through the, you know, slings and arrows of outrageous fortune, we become injured by life, adversity, trauma, get reinforced in a particular way, perhaps for defensive reasons. And so it's not the default function anymore.
Computationally simple but powerful framing that resonates with both lay and technical audiences.

Sign in to share feedback

Tell us if this brief hit the mark or missed it — feedback feeds back into the next iteration of the prompt.

Topics covered

psychedelicsdepressionentropic-brain-hypothesisdefault-mode-networkplasticityneuroplasticitypsilocybinmdma5-meo-dmtibogaineset-and-settingmicrodosingpsychotherapy-integrationbrain-imagingfmrieegmachine-learningai-decodingtreatment-resistant-depressionborderline-personality-disorder
Free account

Make this library yours

Reading is free for everyone. A free account adds the personal layer: save protocols, follow experts, and see how the other experts weigh in on this same topic.

Create a free accountSign in

Where the experts disagree — weekly

One email a week: the sharpest new disagreements and protocols from the library. No spam, unsubscribe anytime.

Educational summary of the cited expert source — not medical advice. Open the source recording linked above and consult a qualified physician before acting on any protocol.